Organometallic compound, light-emitting device including the organometallic compound, and electronic apparatus including the light-emitting device

US12588405B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12588405-B2
Application numberUS-202318241749-A
CountryUS
Kind codeB2
Filing dateSep 1, 2023
Priority dateSep 7, 2022
Publication dateMar 24, 2026
Grant dateMar 24, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are an organometallic compound represented by Formula 1, a light-emitting device including the organometallic compound, and an electronic apparatus including the light-emitting device. The first ligand, L1, of the organometallic compound may include a first polycyclic coordinate ring in which four or more rings are condensed with each other and a second polycyclic coordinate ring in which three or more rings are condensed with each other. M1(L1)n1(L2)n2  Formula 1.

First claim

Opening claim text (preview).

What is claimed is: 1 . An organometallic compound represented by Formula 1: M 1 ( L 1 ) n1 ( L 2 ) n2 ,  Formula 1 wherein, in Formula 1, M 1 is a transition metal, L 1 is a ligand represented by Formula 1A, L 2 is a bidentate ligand, and n1 and n2 are each independently 1 or 2, wherein, in Formula 1A, X 1 is C or N, X 2 is C or N, ring CY 1 and ring CY 2 are each independently a C 5 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, ring CY 1 is a polycyclic group in which four or more rings are condensed with each other, R 1 and R 2 are independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkenyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 alkoxy group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 alkylthio group unsubstituted or substituted with at least one R 10a , a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , a C 1 -C 6 heterocyclic group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryloxy group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 arylthio group unsubstituted or substituted with at least one R 10a , —C(Q 1 )(Q 2 )(Q 3 ), —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O) 2 (Q 1 ), or —P(═O)(Q 1 )(Q 2 ), a1 and a2 are each independently an integer from 1 to 10, R 10a is: deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group; a C 1 -C 60 alkyl, a C 2 -C 60 alkenyl group, a C 2 -C 60 group, or a C 1 -C 60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), —P(═O)(Q 11 )(Q 12 ), or any combination thereof; a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, or a C 6 -C 60 arylthio group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), —P(═O)(Q 21 )(Q 22 ), or any combination thereof; or —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), or —P(═O)(Q 31 )(Q 32 ), and Q 1 to Q 3 , Q 11 to Q 13 , Q 21 to Q 23 , and Q 31 to Q 33 are each independently: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C 1 -C 60 alkyl; a C 2 -C 60 alkenyl group; a C 2 -C 60 alkynyl group; a C 1 -C 60 alkoxy group; or a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof. 2 . The organometallic compound of claim 1 , wherein a part represented by in Formula 1A is a group represented by any one selected from Formulae CY1(1) to CY1(4): wherein, in Formulae CY1(1) to CY1(4), ring CY 11 and ring CY 12 are each independently a C 5 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, X 1 is C or N, Y 1 is O, S, Se, N(R 1a ), C(R 1a )(R 1b ), or Si(R 1a )(R 1b ), Y 2 is O, S, Se, N(R 1c ), C(R 1c )(R 1d ), or Si(R 1c )(R 1d ), R 11 , R 12 , R 1a , R 1b , R 1c , and R 1d are each independently as described with respect to R 1 in Formula 1, a11 and a12 are each independently an integer from 1 to 10, and and *″ each indicate a binding site to a neighboring atom. 3 . The organometallic compound of claim 1 , wherein a part represented by in Formula 1A is a group represented by any one selected from Formulae CY1(1A) to CY1(4A): wherein, in Formulae CY1(1A) to CY1(4A), X 1 is C or N, Y 1 is O, S, Se, N(R 1a ), C(R 1a )(R 1b ), or Si(R 1a )(R 1b ), Y 2 is O, S, Se, N(R 1c ), C(R 1c )(R 1d ), or Si(R 1c )(R 1d ), R 13 , R 14 , R 1a , R 1b , R 1c , and R 1d are each independently as described with respect to R 1 in Formula 1, a13 and a14 are each independently an integer from 1 to 4, and and *″ each indicate a binding site to a neighboring atom. 4 . The organometallic compound of claim 1 , wherein ring CY 2 is i) a polycyclic group in which two or more cyclic groups selected from Group A1 are condensed with each other, ii) a polycyclic group in which two or more cyclic groups selected from Group A2 are condensed with each other, or iii) a polycyclic group in which at least one cyclic group selected from Group A1 and at least one cyclic group selected from Group A2 are condensed with each other: Group A1: a cyclopentane group, a cyclopentadiene group, a furan group, a thiophene group, a pyrrole group, a silole group, an indene group, a benzofuran group, a benzothiophene group, an indole group, a benzosilole group, an oxazole group, an isooxazole group, an oxadiazole group, an isooxadiazole group, an oxatriazole group, an isooxatriazole group, a thiazole group, an isothiazole group, a thiadiazole group, an isothiadiazole group, a thiatriazole group, an isothiatriazole group, a pyrazole group, an imidazole group, a triazole group, a tetrazole group, an azasilole group, a diazasilole group, and a triazasilole group, Group A2: an adamantane group, a norbornane group, a norbornene group, a cyclohexane group, a cyclohexene group, a benzene group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, and a triazine group. 5 . The organometallic compound of claim 1 , wherein a part represented by in Formula 1A is a group represented by any one selected from Formulae CY2(1) to CY2(5): wherein, in Formulae CY2(1) to CY2(5), X 2 is C or N, X 11 is C(Z 11 ) or N, X 12 is C(Z 12 ) or N, X 13 is C(Z 13 ) or N, X 14 is C(Z 14 ) or N, X 21 is C(Z 21 ) or N, X 22 is C(Z 22 ) or N, X 23 is C(Z 23 ) or N, X 24 is C(Z 24 ) or N, Y 3 is O, S, Se, N(R 3a ), C(R 3a )(R 3b ), Si(R 3a )(R 3b ), or Ge(R 3a )(R 3b ), R 21 , R 22 , Z 11 to Z 14 , Z 21 to Z 24 , R 3a , and R 3b are each independently as described with respect to R 2 in Formula 1, and and *″ each indicate a binding site to a neighboring atom.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12588405B2 cover?
Provided are an organometallic compound represented by Formula 1, a light-emitting device including the organometallic compound, and an electronic apparatus including the light-emitting device. The first ligand, L1, of the organometallic compound may include a first polycyclic coordinate ring in which four or more rings are condensed with each other and a second polycyclic coordinate ring in wh…
Who is the assignee on this patent?
Samsung Display Co Ltd
What technology area does this patent fall under?
Primary CPC classification C09K11/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).